
Monica Shaw: Bristol Myers Squibb and Advocate Health Care to Expand Clinical Trial Access
Monica Shaw, SVP of Global Oncology Commercialization for Bristol Myers Squibb, shared a post on LinkedIn:
“The other week I had the great pleasure of meeting with Advocate Health Care who serves more than 5 million patients and operates more than 1,000 sites of care. Special thanks for the robust dialogue on how we might collaborate to ensure patient access to clinical studies. At Bristol Myers Squibb, we believe that making clinical trial information available to patients, investigators and researchers, and physicians is a critical component of our commitment to transparency, scientific exchange and ultimately innovation.”
Ruben Mesa, Executive Director, Atrium Health Wake Forest Baptist Comprehensive Cancer Center, President of Atrium Health Levine Cancer, and Vice Dean for Cancer Programs at Wake Forest School of Medicine, shared this post on LinkedIn, adding:
“Deeply excited for us to work closely with you and the team at Bristol Myers Squibb to decrease the burden of cancer in our communities across.”
More posts featuring Bristol Myers Squibb on OncoDaily.
-
Challenging the Status Quo in Colorectal Cancer 2024
December 6-8, 2024
-
ESMO 2024 Congress
September 13-17, 2024
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023